Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 17;13:5485–5497. doi: 10.2147/IJN.S169825

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Hsu et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

The observation and scoring of tendon adhesion in four experimental groups at 4 weeks postsurgery.

Notes: (A) Tendon adhesion in groups treated with PCL, commercial product (Seprafilm), or PU3 relative to untreated controls at 4 weeks. Solid arrows: the adhesion site; hollow arrows: the physical barrier. (B) Scoring based on gross evaluation of the implantation sites at 4 weeks. Scoring of PU3 films performed better than PCL films (P=0.024) and the untreated control (P=0.002). *P<0.05, with respect to the other groups. Data shown as mean values.

Abbreviations: B, bone; PCL, polycaprolactone; PU, polyurethane; T, tendon.